180 related articles for article (PubMed ID: 28240178)
1. Efficient Colonic Delivery of DsiRNA by Pectin-Coated Polyelectrolyte Complex Nanoparticles: Preparation, Characterization and Improved Gastric Survivability.
Hussain Z; Katas H; Yan SL; Jamaludin D
Curr Drug Deliv; 2017; 14(7):1016-1027. PubMed ID: 28240178
[TBL] [Abstract][Full Text] [Related]
2. Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery.
Maciel VBV; Yoshida CMP; Pereira SMSS; Goycoolea FM; Franco TT
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023400
[TBL] [Abstract][Full Text] [Related]
3. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
Sheng Y; He H; Zou H
Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
[TBL] [Abstract][Full Text] [Related]
4. Pectin-zinc-chitosan-polyethylene glycol colloidal nano-suspension as a food grade carrier for colon targeted delivery of resveratrol.
Andishmand H; Tabibiazar M; Mohammadifar MA; Hamishehkar H
Int J Biol Macromol; 2017 Apr; 97():16-22. PubMed ID: 28064058
[TBL] [Abstract][Full Text] [Related]
5. Solid Lipid Nanoparticles and Chitosan-coated Solid Lipid Nanoparticles as Promising Tool for Silybin Delivery: Formulation, Characterization, and In vitro Evaluation.
Piazzini V; Cinci L; D'Ambrosio M; Luceri C; Bilia AR; Bergonzi MC
Curr Drug Deliv; 2019; 16(2):142-152. PubMed ID: 30306869
[TBL] [Abstract][Full Text] [Related]
6. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
[TBL] [Abstract][Full Text] [Related]
7. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
Wang F; Yang Y; Ju X; Udenigwe CC; He R
J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-Coated Alginate Nanoparticles Enhanced Absorption Profile of Insulin Via Oral Administration.
Jaafar MHM; Hamid KA
Curr Drug Deliv; 2019; 16(7):672-686. PubMed ID: 31250754
[TBL] [Abstract][Full Text] [Related]
9. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA.
Katas H; Abdul Ghafoor Raja M; Ee LC
Drug Dev Ind Pharm; 2014 Nov; 40(11):1443-50. PubMed ID: 23962166
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-pectin hybrid nanoparticles prepared by coating and blending techniques.
Rampino A; Borgogna M; Bellich B; Blasi P; Virgilio F; Cesàro A
Eur J Pharm Sci; 2016 Mar; 84():37-45. PubMed ID: 26772898
[TBL] [Abstract][Full Text] [Related]
11. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
12. Preparation and optimization of N-trimethyl-O-carboxymethyl chitosan nanoparticles for delivery of low-molecular-weight heparin.
Mahjub R; Heidari Shayesteh T; Radmehr M; Vafaei SY; Amini M; Dinarvand R; Dorkoosh FA
Pharm Dev Technol; 2016; 21(1):14-25. PubMed ID: 25255172
[TBL] [Abstract][Full Text] [Related]
13. Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake.
Barbieri S; Sonvico F; Como C; Colombo G; Zani F; Buttini F; Bettini R; Rossi A; Colombo P
J Control Release; 2013 May; 167(3):276-83. PubMed ID: 23428841
[TBL] [Abstract][Full Text] [Related]
14. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
[TBL] [Abstract][Full Text] [Related]
15. Development and in vitro/in vivo evaluation of Zn-pectinate microparticles reinforced with chitosan for the colonic delivery of progesterone.
Gadalla HH; Soliman GM; Mohammed FA; El-Sayed AM
Drug Deliv; 2016 Sep; 23(7):2541-2554. PubMed ID: 25853478
[TBL] [Abstract][Full Text] [Related]
16. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
[TBL] [Abstract][Full Text] [Related]
17. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.
Zhang Y; Zhu W; Zhang H; Han J; Zhang L; Lin Q; Ai F
Int J Pharm; 2017 Oct; 532(1):384-392. PubMed ID: 28903067
[TBL] [Abstract][Full Text] [Related]
18. Development of Pectin-Type B Gelatin Polyelectrolyte Complex for Curcumin Delivery in Anticancer Therapy.
Shih FY; Su IJ; Chu LL; Lin X; Kuo SC; Hou YC; Chiang YT
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453614
[TBL] [Abstract][Full Text] [Related]
19. Quaternized curdlan/pectin polyelectrolyte complexes as biocompatible nanovehicles for curcumin.
Wu LX; Qiao ZR; Cai WD; Qiu WY; Yan JK
Food Chem; 2019 Sep; 291():180-186. PubMed ID: 31006457
[TBL] [Abstract][Full Text] [Related]
20. Encapsulated drug system based on the gels obtained from callus cultures modified pectins.
Günter EA; Popeyko OV; Istomina EI
J Biotechnol; 2019 Jan; 289():7-14. PubMed ID: 30423368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
